AstraZeneca rated the best Delta COVID vaccine

Advertisement

Last week I questioned whether Australia had backed the wrong vaccine, given research suggested that AstraZeneca was more effective against the Delta strain than Pfizer.

A new study analysing COVID-19 related outcomes from Bahrain between December 2020 and July 2021 shows that recipients of the AstraZeneca vaccine were hospitalised less and experienced less death than recipients of three other vaccines – Pfizer, Sinopharm and Sputnik.

Below is a summary of this study:

The full text of this article is available to MacroBusiness subscribers

$1 for your first month, then:
Cancel at any time through our billing provider, Stripe
About the author
Leith van Onselen is Chief Economist at the MB Fund and MB Super. He is also a co-founder of MacroBusiness. Leith has previously worked at the Australian Treasury, Victorian Treasury and Goldman Sachs.